Alpha Cognition Inc. Foreign Currency Transaction Gain (Loss), before Tax
Alpha Cognition Inc. (ACOG) reported Foreign Currency Transaction Gain (Loss), before Tax of -$42.25 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-13
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$42.25K.
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was -$5.53K.
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-03-31 was -$957.00.
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2024-12-31 was -$7.90K, a 158.47% decline year-over-year.
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$37.61K, a 478.82% decline from fiscal 2023.
- Alpha Cognition Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $9.93K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.25K 10-Q · filed 2026-08-13 | -$42.25K 10-Q · filed 2026-08-13 | ||
| 2025-06-30 | -$5.53K 10-Q · filed 2025-08-14 | -$6.49K 10-Q · filed 2025-08-14 | -$14.39K derived: sum of 3 quarters · filed 2025-08-14 | -$22.61K derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | -$957.00 10-Q · filed 2025-05-15 | -$8.86K derived: sum of 2 quarters · filed 2025-05-15 | -$17.07K derived: sum of 3 quarters · filed 2025-05-15 | -$23.94K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-12-31 | -$7.90K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$16.12K derived: sum of 2 quarters · filed 2025-03-31 | -$22.98K derived: sum of 3 quarters · filed 2025-08-14 | -$37.61K 10-K · filed 2025-03-31 |
| 2024-09-30 | -$8.22K 10-Q · filed 2024-11-14 | -$15.08K derived: sum of 2 quarters · filed 2025-08-14 | -$29.71K 10-Q · filed 2024-11-14 | -$16.20K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$6.86K 10-Q · filed 2025-08-14 | -$21.49K 10-Q · filed 2025-08-14 | -$7.98K derived: sum of 3 quarters · filed 2025-08-14 | -$21.28K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$14.63K 10-Q · filed 2025-05-15 | -$1.12K derived: sum of 2 quarters · filed 2025-05-15 | -$14.42K derived: sum of 3 quarters · filed 2025-05-15 | -$32.72K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $13.51K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $211.00 derived: sum of 2 quarters · filed 2025-03-31 | -$18.09K derived: sum of 3 quarters · filed 2025-03-31 | $9.93K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$13.30K 10-Q · filed 2024-11-14 | -$31.60K derived: sum of 2 quarters · filed 2024-11-14 | -$3.58K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$18.30K 10-Q · filed 2024-08-12 | $9.72K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |